1. Home
  2. UTSI vs CVRX Comparison

UTSI vs CVRX Comparison

Compare UTSI & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UTStarcom Holdings Corp.

UTSI

UTStarcom Holdings Corp.

N/A

Current Price

$1.95

Market Cap

22.3M

ML Signal

N/A

Logo CVRx Inc.

CVRX

CVRx Inc.

N/A

Current Price

$0.70

Market Cap

23.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UTSI
CVRX
Founded
1991
2000
Country
China
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.3M
23.1M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
UTSI
CVRX
Price
$1.95
$0.70
Analyst Decision
Hold
Analyst Count
0
7
Target Price
N/A
★ $2.25
AVG Volume (30 Days)
6.6K
★ 764.6K
Earning Date
08-14-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 23.02
EPS
★ N/A
N/A
Revenue
N/A
★ $56,651,000.00
Revenue This Year
N/A
$3.89
Revenue Next Year
N/A
$12.45
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 10.45
52 Week Low
$1.78
$0.67
52 Week High
$3.63
$10.28

Technical Indicators

Market Signals
Indicator
UTSI
CVRX
Relative Strength Index (RSI) 34.88 23.45
Support Level N/A N/A
Resistance Level $2.58 $1.55
Average True Range (ATR) 0.19 0.16
MACD -0.03 -0.03
Stochastic Oscillator 16.17 5.31

Price Performance

Historical Comparison
UTSI
CVRX

About UTSI UTStarcom Holdings Corp.

UTStarcom Holdings Corp is engaged in providing telecommunication and networking products, solutions and services, focusing on optical networking, carrier-class packet optical, network synchronization, broadband products and a Software Defined Networking (SDN) platform optimized for AI networking infrastructure, mobile backhaul, metro aggregation, broadband access and value-added services. The Company operates through two segments: Equipment, which includes the sale of network infrastructure and application products such as broadband and wireless infrastructure technologies, and Services, which generates maximum revenue and provides support and operational services for equipment products. The Company generates maximum revenue from Japan.

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Share on Social Networks: